-
361
Photochemical Treatment of Drosophila APCs Can Eliminate Associated Viruses and Maintain the APC Function for Generating Antigen-Specific CTLs Ex Vivo
Published 2018-01-01“…Using Drosophila APCs, CTLs specific for melanoma antigens have been generated in vitro and adoptively transferred to melanoma patients. …”
Get full text
Article -
362
Expression and Significance of AQP3 in Cutaneous Lesions
Published 2021-01-01“…Only focal AQP3 staining was seen in nevocellular nevus and no AQP3 staining in melanoma. Our findings indicate the function of AQP3 maintained in most skin tumors. …”
Get full text
Article -
363
Kinetics of Mushroom Tyrosinase and Melanogenesis Inhibition by N-Acetyl-pentapeptides
Published 2014-01-01“…The melanogenesis inhibition of Ac-P4 was dose-dependent and did not induce any cytotoxicity on B16F10 melanoma cells.…”
Get full text
Article -
364
Tectonic Keratoplasty to Restore the Bulbar Wall after Block Excision of Benign and Malignant Intraocular Tumors
Published 2019-01-01“…Two patients were affected by anterior uveal malignant melanoma, and 2 patients were referred to us for large epithelial iris cysts with anterior chamber angle involvement and partial corneal failure. …”
Get full text
Article -
365
A Case of Nivolumab-Induced Severe Mononeuropathy Multiplex and Rhabdomyolysis
Published 2017-01-01“…We report an 81-year-old man with multiple liver metastases after tumorectomy for primary mediastinal malignant melanoma, who experienced limb weakness and sensory disturbance after nivolumab monotherapy. …”
Get full text
Article -
366
Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation events
Published 2025-01-01“…Abstract Genotype-informed anticancer therapies such as BRAF inhibitors can show remarkable clinical efficacy in BRAF-mutant melanoma; however, drug resistance poses a major hurdle to successful cancer treatment. …”
Get full text
Article -
367
Correction: The landscape of BRAF transcript and protein variants in human cancer
Published 2025-02-01Get full text
Article -
368
A novel approach to earlobe reconstruction using the V to Y advancement flap
Published 2021-05-01“…All patients had a non-melanoma skin cancer involving the earlobe. All surgeries were performed under local anesthetic at a tertiary care centre in Halifax, Canada. …”
Get full text
Article -
369
Selective expression and significance of ACKR2 in lung aerocytes
Published 2025-01-01“…In vivo models of lung metastasis and inflammation were performed in wild-type (WT) and conditional KO mice by intravenous injection of melanoma and colon cancer cell lines; the induction of acute lung injury model was done by intranasal injection of lipopolysaccharide (LPS). …”
Get full text
Article -
370
Trojan-horse silk fibroin nanocarriers loaded with a re-call antigen to redirect immunity against cancer
Published 2023-01-01“…Proof-of-concept of in vivo efficacy was achieved in an OVA-hyperimmune B16/F10 murine melanoma model: SFNs-OVA or SFNs-CpG were injected, separately or in association, into the subcutaneous peritumoral area. …”
Get full text
Article -
371
Studi Retrospektif Kanker Kulit di Poliklinik Ilmu Kesehatan Kulit dan Kelamin RS Dr. M. Djamil Padang Periode Tahun 2015-2017
Published 2018-10-01“…Kesimpulan: Karsinoma non-melanoma merupakan kanker kulit yang paling banyak ditemukan di dunia. …”
Get full text
Article -
372
Revealing Genomic Profile That Underlies Tropism of Myeloma Cells Using Whole Exome Sequencing
Published 2015-01-01“…Genetic signature of cutaneous plasmacytoma shares that of melanoma implying common mechanism for skin tropism. …”
Get full text
Article -
373
Immunotherapy-associated autoimmune hemolytic anemia
Published 2017-02-01“…The following case represents an unusual adverse effect of combined treatment with ipilimumab and nivolumab used for treatment of metastatic melanoma.Case presentation A 43-year-old woman with metastatic melanoma presented with severe generalized weakness and fatigue. …”
Get full text
Article -
374
Functional-proteomics-based investigation of the cellular response to farnesyltransferase inhibition in lung cancer
Published 2025-02-01“…Key findings include the potential therapeutic value of FTIs for NRAS-mutated melanoma and GNAQ/GNA11-mutated uveal melanoma by inhibiting INPP5A farnesylation. …”
Get full text
Article -
375
A Severe Case of Ipilimumab-Induced Ileocolitis Refractory to Glucocorticosteroids and Infliximab
Published 2018-01-01“…Ipilimumab is a monoclonal antibody that works as an immunotherapeutic agent through selective targeting of T cells to strengthen the response to metastatic melanoma. It is well known that this pharmaceutical agent can cause the adverse effect of colitis. …”
Get full text
Article -
376
CASE PRESENTATION
Published 2024-03-01“…Diffuse large B-cell lymphoma and metachronous metastatic renal cancer – a case report Malignant melanoma of the leg – challenges. A case report Clinical and therapeutic particularities in dermatofibrosarcoma protuberans – a case report Multiple myeloma presenting as sellar plasmacytoma and focal and segmental glomerulosclerosis – case report…”
Get full text
Article -
377
Enhancing magnetic hyperthermia: Investigating iron oxide nanoparticle coating and stability
Published 2025-01-01“…Interaction studies with three cell lines (fibroblasts, melanoma, and macrophages) revealed enhanced internalization of APTES-coated SPIONs. …”
Get full text
Article -
378
Analysis of the Stockholm Public Health Cohort: Exploring How Ultraviolet Radiation and Other Factors Associate with Skin Cancer
Published 2024-01-01“…A 5% level of significance was applied. Melanoma in situ and SCC in situ were excluded. Results. …”
Get full text
Article -
379
Resetting the Hsc70-mediated lysosomal degradation of PD-L1 via a supramolecular meso peptide for the restoration of acquired anti-tumor T cell immunity
Published 2025-02-01“…As expected, CTAC-PDL1 effectively reactivated Hsc70-mediated lysosomal degradation of PD-L1 and consequently restored anti-tumor T cell immunity in a B16F10-derived mouse model of malignant melanoma while maintaining a favorable safety profile. …”
Get full text
Article -
380
Newer Clinical Strategies for Combining Interferon and Cytotoxic Agents Against Solid Tumours and Hematological Malignancies
Published 1994-01-01“…Clinical benefits have been observed for combinations of interferons and alkylating agents against low grade lymphomas, interferons and dacarbazine against malignant melanoma, and interferons and 5-fluorouracil against gastrointestinal and genitourinary malignancies. …”
Get full text
Article